Showing results (71-80 of 365) with videos related to
Sort By:
Pageof 37
The American Journal of Cardiology|January 12, 2020
Usefulness of a Structured Adult Education Program in Modifying Markers of Cardiovascular Risk After Acute Myocardial InfarctionGeorgios Giannopoulos, Sofia Karageorgiou, Dimitrios Vrachatis, et al.Current Topics in Medicinal Chemistry|June 11, 2013
Prognostic role of miRNAs in coronary artery diseaseNikolaos Papageorgiou, Dimitris Tousoulis, Marietta Charakida, et al.Pharmacology & Therapeutics|June 15, 2014
Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approachesDimitris Tousoulis, Chryssa Simopoulou, Nikos Papageorgiou, et al.Current Pharmaceutical Design|December 30, 2011
Inflammation in hypertension: current therapeutic approachesEmmanuel Androulakis, Dimitris Tousoulis, Nikolaos Papageorgiou, et al.Current Topics in Medicinal Chemistry|June 11, 2013
Diagnostic and therapeutic potentials of microRNAs in heart failureEvangelos Oikonomou, Gerasimos Siasos, Dimitris Tousoulis, et al.Current Medicinal Chemistry|June 10, 2008
New biochemical markers in acute coronary syndromesDimitris Tousoulis, Anna-Maria Kampoli, Elli Stefanadi, et al.Current Pharmaceutical Design|July 22, 2022
The Complex Relationship Between Diabetes and Cardiac Arrhythmias: Pathophysiology and MechanismsMichael Spartalis, Panteleimon Pantelidis, Christos Kontogiannis, et al.Current Cardiology Reviews|February 14, 2017
High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary SyndromesEmmanuel Androulakis, Effimia Zacharia, Nikolaos Papageorgiou, et al.Recent Patents on Cardiovascular Drug Discovery|August 20, 2013
Antioxidant treatment and endothelial dysfunction: is it time for flavonoids?Nikolaos Papageorgiou, Dimitris Tousoulis, Athanasios Katsargyris, et al.Biomedicines|October 29, 2025
The Role of miRNAs in Chemotherapy-Induced CardiotoxicityMaria Anastasiou, Evangelos Oikonomou, Panagiotis Theofilis, et al.Pageof 37